OLUMIANT Trademark

Trademark Overview

On Friday, April 24, 2015, a trademark application was filed for OLUMIANT with the United States Patent and Trademark Office. The USPTO has given the OLUMIANT trademark a serial number of 86608577. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 10, 2018. This trademark is owned by Eli Lilly and Company. The OLUMIANT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for treating autoimmune diseases and disorders and psoriasis
olumiant

General Information

Serial Number86608577
Word MarkOLUMIANT
Filing DateFriday, April 24, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 10, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 8, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for treating autoimmune diseases and disorders and psoriasis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 5, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Monday, December 10, 2018ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 10, 2018ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 23, 2018ASSIGNED TO EXAMINER
Tuesday, May 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 7, 2018EXTENSION 5 GRANTED
Friday, April 20, 2018EXTENSION 5 FILED
Monday, May 7, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 20, 2018TEAS EXTENSION RECEIVED
Saturday, October 28, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 26, 2017EXTENSION 4 GRANTED
Thursday, October 26, 2017EXTENSION 4 FILED
Thursday, October 26, 2017TEAS EXTENSION RECEIVED
Tuesday, May 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 28, 2017EXTENSION 3 GRANTED
Friday, April 28, 2017EXTENSION 3 FILED
Friday, April 28, 2017TEAS EXTENSION RECEIVED
Thursday, March 9, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 9, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 8, 2016EXTENSION 2 GRANTED
Monday, October 24, 2016EXTENSION 2 FILED
Tuesday, November 8, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 24, 2016TEAS EXTENSION RECEIVED
Tuesday, March 29, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 25, 2016EXTENSION 1 GRANTED
Friday, March 25, 2016EXTENSION 1 FILED
Friday, March 25, 2016TEAS EXTENSION RECEIVED
Tuesday, November 3, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 8, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 8, 2015PUBLISHED FOR OPPOSITION
Wednesday, August 19, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, August 1, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, July 31, 2015ASSIGNED TO LIE
Tuesday, July 21, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 20, 2015ASSIGNED TO EXAMINER
Tuesday, May 5, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 28, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

olumiant pharmaceutical preparations disorders psoriasis diseases treating namely autoimmune